Literature DB >> 11702015

Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine.

A Tortorella1, P Monteleone, M Fabrazzo, A Viggiano, L De Luca, M Maj.   

Abstract

Peripheral amino acid changes have been reported in schizophrenia, but results are not consistent. We measured serum levels of different amino acids in 11 neuroleptic-resistant schizophrenic patients before and after clozapine treatment and in 11 age- and sex-matched healthy subjects. The schizophrenic patients exhibited significantly higher levels of serum aspartate, glutamate, isoleucine, histidine and tyrosine and significantly lower concentrations of serum asparagine, tryptophan and serine. In patients, the ratio between tryptophan and large neutral amino acids (LNAA) was significantly lower than in matched controls, whereas the tyrosine/LNAA ratio did not differ significantly. Moreover, 12 weeks of clozapine administration significantly reduced serum levels of glutamate but did not restore the values observed in normal controls, nor did it affect other amino acid concentrations. These data show changes in serum amino acids that may influence central serotonergic, dopaminergic and glutamatergic transmission in neuroleptic-resistant schizophrenics. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702015     DOI: 10.1159/000054937

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  17 in total

1.  Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.

Authors:  Surendra P Singh; Vidhi Singh
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

2.  An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder.

Authors:  Kyle J Burghardt; Simon J Evans; Kristen M Wiese; Vicki L Ellingrod
Journal:  Clin Transl Sci       Date:  2015-08-27       Impact factor: 4.689

Review 3.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

Review 4.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

Review 5.  Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide.

Authors:  Abdulla Badawy
Journal:  Psychopharmacology (Berl)       Date:  2013-07-05       Impact factor: 4.530

6.  The relation between peripheral and central glutamate and glutamine in healthy male volunteers.

Authors:  Yanina Shulman; Suzanne Grant; Peter Seres; Chris Hanstock; Glen Baker; Philip Tibbo
Journal:  J Psychiatry Neurosci       Date:  2006-11       Impact factor: 6.186

7.  The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.

Authors:  Abbas F Almulla; Asara Vasupanrajit; Chavit Tunvirachaisakul; Hussein K Al-Hakeim; Marco Solmi; Robert Verkerk; Michael Maes
Journal:  Mol Psychiatry       Date:  2022-04-14       Impact factor: 15.992

8.  Tryptophan Metabolism and White Matter Integrity in Schizophrenia.

Authors:  Joshua Chiappelli; Teodor T Postolache; Peter Kochunov; Laura M Rowland; S Andrea Wijtenburg; Dinesh K Shukla; Malle Tagamets; Xiaoming Du; Anya Savransky; Christopher A Lowry; Adem Can; Dietmar Fuchs; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2016-05-04       Impact factor: 7.853

9.  Schizophrenia shows a unique metabolomics signature in plasma.

Authors:  Y He; Z Yu; I Giegling; L Xie; A M Hartmann; C Prehn; J Adamski; R Kahn; Y Li; T Illig; R Wang-Sattler; D Rujescu
Journal:  Transl Psychiatry       Date:  2012-08-14       Impact factor: 6.222

10.  Peripheral amino Acid levels in schizophrenia and antipsychotic treatment.

Authors:  Vincenzo De Luca; Emanuela Viggiano; Giovanni Messina; Alessandro Viggiano; Carol Borlido; Andrea Viggiano; Marcellino Monda
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.